Viral characterization of the reassortants between canine influenza H3N2 and human pandemic (2009) H1N1 and avian H9N2 viruses in canine ex vivo tracheal explants
In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a...
Saved in:
Published in | Virology journal Vol. 22; no. 1; pp. 218 - 10 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
01.07.2025
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential.
We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile.
Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk.
Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population. |
---|---|
AbstractList | In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential.BACKGROUNDIn 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential.We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile.METHODSWe conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile.Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk.RESULTSCo-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk.Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population.CONCLUSIONSOur results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population. Abstract Background In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential. Methods We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile. Results Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk. Conclusions Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population. In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential. We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile. Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk. Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population. Background In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential. Methods We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile. Results Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk. Conclusions Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population. Keywords: Influenza, Canine H3N2, Pandemic H1N1, H9N2, Reassortment, Ex vivo, Explants In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and continues to circulate in the canines. While there is currently no report of H3N2-CIV spilling over to the human population, the virus had shown a tendency to reassort with other influenza subtypes. Given that the canine respiratory tract is susceptible to a wide range of influenza viruses, it is of interest whether H3N2-CIV are likely to reassort with human and avian IAVs to generate reassortants with increased zoonotic potential. We conducted a co-infection study in canine tracheal explants. Ex vivo canine tracheal tissues were co-infected by H3N2-CIV and two respective human and avian influenza viruses, 2009 pandemic H1N1 and avian H9N2 virus. The viruses were serially passaged in canine tracheal explants. Next-generation sequencing was conducted to investigate the reassortment pattern. The resulting reassortants were plaque-purified and inoculated in human alveolar epithelial cells to determine their replication competence and proinflammatory cytokine induction profile. Co-passaging H3N2-CIV with human/avian influenza A viruses in canine tracheal explants resulted in a high rate of reassortment. Plaque-purified reassortants were all viable and able to propagate in mammalian alveolar epithelial cells. Reassortment most frequently occurred in the MP, NA and NS segments. Selected reassortants had enhanced replication efficiency and able to induce more proinflammatory cytokines than the parental strains, suggesting that these reassortants have a considerable zoonotic risk. Our results demonstrate that ex vivo canine tracheal explants can serve as an effective platform for studying influenza virus reassortment and evolution. The ability of H3N2-CIV reassortants to replicate and induce a proinflammatory cytokine response in human alveolar epithelial cells substantiates the zoonotic potential of canine-origin influenza A viruses and suggests a risk of enhanced transmission acquired through reassortment events. These findings highlight the need for ongoing surveillance and constant vigilance regarding influenza viruses circulating in the canine population. |
ArticleNumber | 218 |
Audience | Academic |
Author | Peiris, Malik Hui, Kenrie P. Y. Kam, Tonia T. Chan, Michael C. W. Bui, Christine H. T. Wong, Peter C. H. Poon, Leo L. M. Yeung, Hin-Wo Chin, Alex W. H. Nicholls, John M. |
Author_xml | – sequence: 1 givenname: Tonia T. surname: Kam fullname: Kam, Tonia T. – sequence: 2 givenname: Christine H. T. surname: Bui fullname: Bui, Christine H. T. – sequence: 3 givenname: Hin-Wo surname: Yeung fullname: Yeung, Hin-Wo – sequence: 4 givenname: Peter C. H. surname: Wong fullname: Wong, Peter C. H. – sequence: 5 givenname: Alex W. H. surname: Chin fullname: Chin, Alex W. H. – sequence: 6 givenname: John M. surname: Nicholls fullname: Nicholls, John M. – sequence: 7 givenname: Malik surname: Peiris fullname: Peiris, Malik – sequence: 8 givenname: Kenrie P. Y. surname: Hui fullname: Hui, Kenrie P. Y. – sequence: 9 givenname: Leo L. M. surname: Poon fullname: Poon, Leo L. M. – sequence: 10 givenname: Michael C. W. surname: Chan fullname: Chan, Michael C. W. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40597362$$D View this record in MEDLINE/PubMed |
BookMark | eNptkttq3DAQhk1JaQ7tC_SiCHqTXDjVwbasqxJC2w2EFHqid2JWO95V8EpbSd5u8zh90sq7SchCMcZi5pvfM6P_uDhw3mFRvGb0nLG2eRcZV21dUj6-rWhK9qw4YrISZcX5z4Mn58PiOMZbSgVvpHpRHFa0VlI0_Kj4-8MG6IlZQACTMNg7SNY74juSFkgCQow-JHApkimm34iOGHDWIbGu6wd0d0Am4oYTcDOyGJbgyCofcWkNOeWUqjMyYTdsm4a1zemJyvTahiFizCIPcrjJwbUnKTeywNwTblb9-N-XxfMO-oiv7r8nxfePH75dTsrrz5-uLi-uS1NzkUqokbGqbZACq6Sh1bgcVs3QMOC8lh2bYkMlzZSkVCKXleJMNpVpOiVELU6Kq53uzMOtXgW7hPBHe7B6G_BhriEka3rUYFrBZ5WsMddD10wlTlWrhFK1bKE1Wev9Tms1TJc4M-jyWP2e6H7G2YWe-7VmPPekqMgKp_cKwf8aMCa9tNFgn1eCfohacN6IWol2RN_u0Dnk3vK1-HGHI64v2qoRVFWyzdT5f6j8bO8qO6uzOb5XcLZXkJmEmzSHIUZ99fXLPvvm6byPgz4YLQN8B5jgYwzYPSKM6tHNeudmnd2st27WTPwD2v_kOg |
Cites_doi | 10.4172/1747-0862.1000028 10.1128/JVI.00887-14 10.1093/infdis/jiab002 10.1371/journal.ppat.1008409 10.1016/0042-6822(79)90430-6 10.1128/JVI.00702-11 10.1128/jvi.01763-01716 10.1128/JVI.00637-17 10.1128/JVI.01140-10 10.1111/j.1750-2659.2012.00379.x 10.1017/S0950268814001617 10.1099/vir.0.037739-0 10.1016/j.vetmic.2020.108970 10.1371/journal.pone.0162163 10.7554/eLife.83470 10.1016/j.vetmic.2009.01.019 10.1007/s11262-015-1272-z 10.1073/pnas.96.16.9363 10.1016/S0140-6736(02)11772-7 10.1136/bmjresp-2023-001638 10.1016/j.virusres.2014.08.020 10.1186/s12985-015-0343-z 10.3201/eid2510.190196 10.1128/JVI.72.9.7367-7373.1998 10.1016/j.vetmic.2010.12.011 10.1186/s13567-017-0453-2 10.1055/s-0036-1584801 10.3201/eid1405.071471 10.1016/j.meegid.2012.11.018 10.1093/molbev/msv044 10.3201/eid2312.170246 |
ContentType | Journal Article |
Copyright | 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. The Author(s) 2025 2025 |
Copyright_xml | – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: The Author(s) 2025 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 7X8 5PM DOA |
DOI | 10.1186/s12985-025-02836-1 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1743-422X |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_ac832d475e764af6b7eb989399578a8c PMC12217903 A846309478 40597362 10_1186_s12985_025_02836_1 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Hong Kong, China |
GeographicLocations_xml | – name: Hong Kong, China |
GrantInformation_xml | – fundername: NIH HHS grantid: 75N93021C00016 – fundername: Theme-Based Research Scheme, University Grants Committee grantid: T11-712/19-N – fundername: NIAID NIH HHS grantid: 75N93021C00016 – fundername: InnoHK grantid: C2i – fundername: Health and Medical Research Fund grantid: 18171262 |
GroupedDBID | --- 0R~ 123 29Q 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAHBH AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IGS IHR INH INR ISR ITC KQ8 LGEZI LOTEE M1P M~E NADUK NXXTH O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c523t-a5e11486e0a147c04298514dec1a2257f1be6070e117007e274921764c6f93353 |
IEDL.DBID | DOA |
ISSN | 1743-422X |
IngestDate | Wed Aug 27 01:31:12 EDT 2025 Thu Aug 21 18:33:36 EDT 2025 Fri Jul 11 16:55:12 EDT 2025 Wed Jul 16 16:53:06 EDT 2025 Tue Jul 15 03:51:54 EDT 2025 Sat Jul 12 02:48:24 EDT 2025 Sat Aug 02 01:40:57 EDT 2025 Thu Jul 03 08:32:23 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Explants Canine H3N2 Ex vivo H9N2 Influenza Pandemic H1N1 Reassortment |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c523t-a5e11486e0a147c04298514dec1a2257f1be6070e117007e274921764c6f93353 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/ac832d475e764af6b7eb989399578a8c |
PMID | 40597362 |
PQID | 3226359383 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ac832d475e764af6b7eb989399578a8c pubmedcentral_primary_oai_pubmedcentral_nih_gov_12217903 proquest_miscellaneous_3226359383 gale_infotracmisc_A846309478 gale_infotracacademiconefile_A846309478 gale_incontextgauss_ISR_A846309478 pubmed_primary_40597362 crossref_primary_10_1186_s12985_025_02836_1 |
PublicationCentury | 2000 |
PublicationDate | 2025-07-01 |
PublicationDateYYYYMMDD | 2025-07-01 |
PublicationDate_xml | – month: 07 year: 2025 text: 2025-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Virology journal |
PublicationTitleAlternate | Virol J |
PublicationYear | 2025 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | L Martinez-Sobrido (2836_CR21) 2020; 16 A Moreno (2836_CR16) 2011; 149 CKP Mok (2836_CR22) 2011; 85 IH Lee (2836_CR15) 2016; 52 C Wang (2836_CR24) 2016; 11 C Cheung (2836_CR27) 2002; 360 T Ito (2836_CR8) 1998; 72 H Sun (2836_CR29) 2017; 91 H Kim (2836_CR6) 2013; 7 W Na (2836_CR12) 2015; 12 C Lee (2836_CR5) 2009; 137 D Song (2836_CR13) 2012; 93 W Ma (2836_CR9) 2009; 3 JS Weese (2836_CR3) 2019; 25 D Zhao (2836_CR31) 2021; 253 K-S Lyoo (2836_CR7) 2015; 195 2836_CR17 KB Zeldovich (2836_CR23) 2015; 32 CP Octaviani (2836_CR18) 2010; 84 G Gonzalez (2836_CR11) 2014; 88 D Song (2836_CR1) 2008; 14 H Moon (2836_CR14) 2015; 143 M Chen (2836_CR30) 2023; 12 S Su (2836_CR4) 2013; 14 IE Voorhees (2836_CR2) 2017; 23 MD Lubeck (2836_CR28) 1979; 95 M Gu (2836_CR19) 2017; 48 CH Bui (2836_CR10) 2021; 224 2836_CR25 Z Luyan (2836_CR26) 2023; 10 2836_CR20 |
References_xml | – volume: 3 start-page: 158 issue: 1 year: 2009 ident: 2836_CR9 publication-title: J Mol Genetic Medicine: Int J Biomedical Res doi: 10.4172/1747-0862.1000028 – volume: 88 start-page: 9208 issue: 16 year: 2014 ident: 2836_CR11 publication-title: J Virol doi: 10.1128/JVI.00887-14 – volume: 224 start-page: 821 issue: 5 year: 2021 ident: 2836_CR10 publication-title: J Infect Dis doi: 10.1093/infdis/jiab002 – volume: 16 start-page: e1008409 issue: 4 year: 2020 ident: 2836_CR21 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1008409 – volume: 95 start-page: 269 issue: 1 year: 1979 ident: 2836_CR28 publication-title: Virology doi: 10.1016/0042-6822(79)90430-6 – volume: 85 start-page: 9641 issue: 18 year: 2011 ident: 2836_CR22 publication-title: J Virol doi: 10.1128/JVI.00702-11 – ident: 2836_CR17 doi: 10.1128/jvi.01763-01716 – volume: 91 start-page: jvi10112800637 issue: 21 year: 2017 ident: 2836_CR29 publication-title: J Virol doi: 10.1128/JVI.00637-17 – volume: 84 start-page: 10918 issue: 20 year: 2010 ident: 2836_CR18 publication-title: J Virol doi: 10.1128/JVI.01140-10 – volume: 7 start-page: 265 issue: 3 year: 2013 ident: 2836_CR6 publication-title: Influenza Other Respir Viruses doi: 10.1111/j.1750-2659.2012.00379.x – volume: 143 start-page: 772 issue: 4 year: 2015 ident: 2836_CR14 publication-title: Epidemiol Infect doi: 10.1017/S0950268814001617 – volume: 93 start-page: 551 issue: 3 year: 2012 ident: 2836_CR13 publication-title: J Gen Virol doi: 10.1099/vir.0.037739-0 – volume: 253 start-page: 108970 year: 2021 ident: 2836_CR31 publication-title: Vet Microbiol doi: 10.1016/j.vetmic.2020.108970 – volume: 11 start-page: e0162163 issue: 9 year: 2016 ident: 2836_CR24 publication-title: PLoS ONE doi: 10.1371/journal.pone.0162163 – volume: 12 start-page: e83470 year: 2023 ident: 2836_CR30 publication-title: Elife doi: 10.7554/eLife.83470 – volume: 137 start-page: 359 issue: 3–4 year: 2009 ident: 2836_CR5 publication-title: Vet Microbiol doi: 10.1016/j.vetmic.2009.01.019 – volume: 52 start-page: 142 year: 2016 ident: 2836_CR15 publication-title: Virus Genes doi: 10.1007/s11262-015-1272-z – ident: 2836_CR20 doi: 10.1073/pnas.96.16.9363 – volume: 360 start-page: 1831 issue: 9348 year: 2002 ident: 2836_CR27 publication-title: Lancet doi: 10.1016/S0140-6736(02)11772-7 – volume: 10 start-page: e001638 issue: 1 year: 2023 ident: 2836_CR26 publication-title: BMJ Open Respiratory Res doi: 10.1136/bmjresp-2023-001638 – volume: 195 start-page: 135 year: 2015 ident: 2836_CR7 publication-title: Virus Res doi: 10.1016/j.virusres.2014.08.020 – volume: 12 start-page: 1 year: 2015 ident: 2836_CR12 publication-title: Virol J doi: 10.1186/s12985-015-0343-z – volume: 25 start-page: 1810 issue: 10 year: 2019 ident: 2836_CR3 publication-title: Emerg Infect Dis doi: 10.3201/eid2510.190196 – volume: 72 start-page: 7367 issue: 9 year: 1998 ident: 2836_CR8 publication-title: J Virol doi: 10.1128/JVI.72.9.7367-7373.1998 – volume: 149 start-page: 472 issue: 3 year: 2011 ident: 2836_CR16 publication-title: Vet Microbiol doi: 10.1016/j.vetmic.2010.12.011 – volume: 48 start-page: 1 year: 2017 ident: 2836_CR19 publication-title: Vet Res doi: 10.1186/s13567-017-0453-2 – ident: 2836_CR25 doi: 10.1055/s-0036-1584801 – volume: 14 start-page: 741 issue: 5 year: 2008 ident: 2836_CR1 publication-title: Emerg Infect Dis doi: 10.3201/eid1405.071471 – volume: 14 start-page: 444 year: 2013 ident: 2836_CR4 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2012.11.018 – volume: 32 start-page: 1519 issue: 6 year: 2015 ident: 2836_CR23 publication-title: Mol Biol Evol doi: 10.1093/molbev/msv044 – volume: 23 start-page: 1950 issue: 12 year: 2017 ident: 2836_CR2 publication-title: Emerg Infect Dis doi: 10.3201/eid2312.170246 |
SSID | ssj0032679 |
Score | 2.4089413 |
Snippet | In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread internationally and... Background In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread... Abstract Background In 2007, the canine influenza H3N2 virus (H3N2-CIV) first emerged in the canine population in South Korea. The virus had since spread... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 218 |
SubjectTerms | Animals Canine H3N2 Coinfection - virology Dog Diseases - virology Dogs Ex vivo Genetic aspects H9N2 Humans Influenza Influenza A Virus, H1N1 Subtype - genetics Influenza A Virus, H1N1 Subtype - isolation & purification Influenza A Virus, H1N1 Subtype - physiology Influenza A Virus, H3N2 Subtype - genetics Influenza A Virus, H3N2 Subtype - isolation & purification Influenza A Virus, H3N2 Subtype - physiology Influenza A Virus, H9N2 Subtype - genetics Influenza A Virus, H9N2 Subtype - isolation & purification Influenza A Virus, H9N2 Subtype - physiology Influenza viruses Influenza, Human - virology Orthomyxoviridae Infections - veterinary Orthomyxoviridae Infections - virology Pandemic H1N1 Physiological aspects Reassortant Viruses - genetics Reassortant Viruses - isolation & purification Reassortment Trachea - virology Virus research |
Title | Viral characterization of the reassortants between canine influenza H3N2 and human pandemic (2009) H1N1 and avian H9N2 viruses in canine ex vivo tracheal explants |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40597362 https://www.proquest.com/docview/3226359383 https://pubmed.ncbi.nlm.nih.gov/PMC12217903 https://doaj.org/article/ac832d475e764af6b7eb989399578a8c |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgCMQLggFbYFQGIQFC0eo68cdjhzaFSqvQxlDfLMdxINJIqqWtgD-Hv5S7fFSNeOCFhyiSffmw73z3u-R8R8jrKE9Zxiys79zbMAL1FyrBVJhznmumvYwtOornc5FcRbNFvNgp9YUxYW164Hbijq0DmcsiGXspIpuLVPpUg5HVGmTNKofaF2xe70y1OhgwidT9Fhkljmuwagp3IuOhuAjZwAw12fr_1sk7RmkYMLljgc4ekgcddKTT9pUfkVu-3Cd322KSP_fJvfPuN_lj8vtLAddTt03G3O61pFVOAe9RjEOvEXaXq5p2gVoUphiupUVbtOSXpQmfT6gtM9qU8aNL_Nr8vXD0Lf7peEcTNmdNt92AhNFEA_WmuFnXvoab9LfzP6BxU1EYj0NMCg3La3zuE3J1dvr5QxJ2xRhCB77qKrSxR9dJ-LFlkXRoxwCsRZl3zIJOkDlLvQD94bGUzVh68HY1uDsiciLXnMf8Kdkrq9IfEqpTrxzACOszcGZSphVgGJbF1rt4bLkOyPueN2bZ5twwja-ihGk5aYCTpuGkYQE5QfZtKTFfdtMAUmQ6KTL_kqKAvELmG8yIUWLIzVe7rmvz8fLCTAGhcXCCpQrIm44or3DabLeDAUaFSbQGlEcDSliybtD9spcxg10Y51b6al0bUK-AADVXPCAHrcxtBwbQWkvAGwFRA2kcjHzYUxbfmozhbDLBTGz82f-Yq-fk_qRZSRizfET2Vjdr_wKQ2SodkdtyIUfkznQ6u5zB-eR0_uli1CzNP-MmNwE |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Viral+characterization+of+the+reassortants+between+canine+influenza+H3N2+and+human+pandemic+H1N1+and+avian+H9N2+viruses+in+canine+ex+vivo+tracheal+explants&rft.jtitle=Virology+journal&rft.au=Kam%2C+Tonia+T&rft.au=Bui%2C+Christine+H.+T&rft.au=Yeung%2C+Hin-Wo&rft.au=Wong%2C+Peter+C.+H&rft.date=2025-07-01&rft.pub=BioMed+Central+Ltd&rft.issn=1743-422X&rft.eissn=1743-422X&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs12985-025-02836-1&rft.externalDBID=ISR&rft.externalDocID=A846309478 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-422X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-422X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-422X&client=summon |